Stock DSGN DESIGN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Design Therapeutics, Inc.

Equities

DSGN

US25056L1035

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
4.36 USD +8.19% Intraday chart for Design Therapeutics, Inc. -1.13% +64.53%
May. 08 Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. DSGN Stock
  4. Revisions Design Therapeutics, Inc.